Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6359.0000 -14.00 (-0.22%)
NSE Nov 24, 2025 15:31 PM
Volume: 393.8K
 

6359.00
-0.22%
Karvy
Divis Labs Net revenues increased by 6.2% YoY to Rs 10.4 bn, higher thanour estimates of Rs 9.8 bn for the quarter. The Operating margins were at31.4% in Q3 FY18 (lower than our estimate of 32.9%) as against 38.7% inQ3FY17 on account of lower gross margin and higher other expenses.
Deven Choksey increased Accumulate price target of Divi's Laboratories Ltd. to 6795.0 on 20 Nov, 2025.
More from Divi's Laboratories Ltd.
Recommended